No Efficacy or Safety Issues: Achieve Life Sciences Gets FDA CRL for Cytisinicline

Achieve Life Sciences received an FDA Complete Response Letter for its cytisinicline NDA due to manufacturing issues at a former facility. No efficacy or safety deficiencies were identified.